GATC Biotech Presents Novel Sequencing Approaches for Basic Science and Clinical Research at the Analytica in Munich, Germany

Hall A3, Stand 100

2 May 2016
Lois Manton-O'Byrne
Executive Editor

Europe’s leading sequencing service provider invites you to booth #100 in hall A3. Visitors will have the exclusive opportunity to meet with a team of sequencing specialists and discuss established sample-to-data solutions for analysis of whole genomes, exomes, transcriptomes, microbiomes and epigenomes among many others.

Stand visits can be complemented with a talk of next-generation sequencing (NGS) expert, Dr Bernhard Busch. The presentation, entitled “Recent Advancements in NGS and their Implications for Researchers and Clinicians”, will take place on May 10th from 11:00 to 11:30 in the Biotech Forum. Attendees will learn more about the key elements of GATCLIQUID, the company’s liquid biopsy-based service for non-invasive cancer research and diagnostics.

Besides NGS, GATC Biotech will showcase its popular Sanger sequencing services with fastest processing times and exceptional data quality, as well as MYCOPLASMACHECK, a qPCR-based test for detection of mycoplasma contamination in cell culture. GATC Biotech representatives will be happy to illustrate how outsourcing mycoplasma testing via MYCOPLASMACHECK can lead to cost-efficient, easy and accurate quality control of cell lines.

Above all, the GATC Biotech team has prepared a little surprise for all stand visitors. So stay curious – GATC is looking forward to many productive discussions with sequencing enthusiasts at the Analytica 2016 in Munich.

Find out more about GATC Sequencing Solutions.

Links

Tags